Cite

HARVARD Citation

    Durie, B. et al. (n.d.). Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma. American journal of hematology. 95 (12), pp. 1486-1494. [Online]. 
  
Back to record